Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novavax
Pharma
Novavax investor Shah Capital jabs at vaccine maker
Novavax investor Shah Capital is claiming the vaccine developer has been “historically mismanaged” and is trying to install two of its own board picks.
Gabrielle Masson
Apr 15, 2024 10:48am
After cuts, Novavax's Q4 performance startles investors
Feb 28, 2024 9:38am
Novavax paying up to $400M to evade Gavi COVID shot arbitration
Feb 22, 2024 6:00am
Novavax taps breakout star of TV show for COVID vaccine campaign
Oct 10, 2023 9:00am
Moderna presents strong preliminary data for updated COVID shot
Aug 18, 2023 11:00am
COVID vaccine makers test shots against dominant new variant
Aug 15, 2023 11:09am